SYED RAZA: Open Payments
NPI 1841220241 · HARLAN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 14 payments from 6 companies in 2025. Trend: 2023 $187 · 2024 $135 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Alkermes, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: COBENFY, SPRAVATO, ARISTADA, Vyloy, CAPLYTA, HETLIOZ.
Industry payments across KY — which companies pay providers there.
